Glioblastoma is an aggressive and inevitably recurrent primary intra-axial brain tumor with a
dismal prognosis. The current mainstay of treatment involves maximally safe surgical …

With the rapid development of new technologies, including artificial intelligence and genome
sequencing, radiogenomics has emerged as a state-of-the-art science in the field of …

Radiomics relies on the extraction of a wide variety of quantitative image-based features to
provide decision support. Magnetic resonance imaging (MRI) contributes to the …

Recent advances in radiomics have enhanced the value of medical imaging in various
aspects of clinical practice, but a crucial component that remains to be investigated further is …

This study aimed to investigate the feasibility of predicting oxygen 6-methylguanine-DNA
methyltransferase (MGMT) promoter methylation in diffuse gliomas by develo** a deep …

Introduction Being the most common primary brain tumor, glioblastoma presents as an
extremely challenging malignancy to treat with dismal outcomes despite treatment. Varying …

Neuro-oncology largely consists of malignancies of the brain and central nervous system
including both primary as well as metastatic tumors. Currently, a significant clinical …

Survival analysis is a critical task in glioma patient management due to the inter and intra
tumor heterogeneity. In clinical practice, clinicians estimate the survival with their …

The accurate prognosis of glioblastoma multiforme (GBM) plays an essential role in
planning correlated surgeries and treatments. The conventional models of survival …

Introduction Survival varies in patients with glioblastoma due to intratumoral heterogeneity
and radiomics/imaging biomarkers have potential to demonstrate heterogeneity. The …